Articles

Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study

Institut de Cancérologie Gustave Roussy, Villejuif, France
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
CLCC Institut Paoli Calmettes, Marseille, France
National Cancer Center Singapore, Duke-National University of Singapore Medical School, Singapore
Hospices Civils de Lyon, France
Department of Hematology, Faculty of Medicine, University of Debrecen Medical and Health Science Center, Hungary
CHUM, Montreal, QC, Canada
Ernest and Helen Scott Haematological Research Institute, University of Leicester, UK
Universitair Ziekenhuis Gent, Gent, Belgium
Servier, Paris, France
Servier, Paris, France
Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA
Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA
Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA
Department of Hematology, Université de Lille, EA GRIIOT, France
Vol. 102 No. 5 (2017): May, 2017 https://doi.org/10.3324/haematol.2016.154377